Work

Comparison of incidence and average cost per toxicity in patients treated with nivolumab and pembrolizumab.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.e18292

Authors: Neil Thomas Mason, Scott Joseph Antonia, Nikhil I. Khushalani, Howard L. McLeod

Institution: Moffitt Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890960142

Cites:

Cited by:

Related to: 10